Shanghai Pharmaceuticals Correlations
| S1R Stock | EUR 1.50 0.01 0.67% |
The current 90-days correlation between Shanghai Pharmaceuticals and Casio Computer CoLtd is 0.01 (i.e., Significant diversification). The correlation of Shanghai Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Shanghai Pharmaceuticals Correlation With Market
Significant diversification
The correlation between Shanghai Pharmaceuticals Holdi and DJI is 0.03 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Shanghai Pharmaceuticals Holdi and DJI in the same portfolio, assuming nothing else is changed.
Shanghai |
The ability to find closely correlated positions to Shanghai Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Shanghai Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Shanghai Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Shanghai Pharmaceuticals Holding to buy it.
Moving together with Shanghai Stock
| 0.72 | CLH | Cardinal Health | PairCorr |
| 0.71 | HS2 | Henry Schein | PairCorr |
| 0.86 | X2S | Sinopharm Group | PairCorr |
| 0.82 | PBV | Prestige Consumer | PairCorr |
| 0.76 | ESLC | ESSILORLUXOTTICA 12ON | PairCorr |
| 0.71 | GLE | Gladstone Commercial | PairCorr |
| 0.65 | CRG | CRH plc | PairCorr |
| 0.77 | UOF | Urban Outfitters | PairCorr |
| 0.76 | CJH | CanSino Biologics | PairCorr |
| 0.79 | AW8 | Air Transport Services | PairCorr |
| 0.86 | MSF | Microsoft | PairCorr |
| 0.66 | 8N4 | FIRST SAVINGS FINL | PairCorr |
| 0.76 | 7SU | Summit Materials | PairCorr |
| 0.88 | LIE | Sun Life Financial | PairCorr |
| 0.85 | 0VF | Virtu Financial Earnings Call This Week | PairCorr |
| 0.78 | H0O | REVO INSURANCE SPA | PairCorr |
| 0.81 | TLX | Talanx AG | PairCorr |
| 0.62 | 5UM | Genertec Universal | PairCorr |
Moving against Shanghai Stock
| 0.85 | CJ8A | CARGOJET INC VAR | PairCorr |
| 0.79 | 99Q | ENTREPARTICULIERS EO | PairCorr |
| 0.77 | 7EL | Elis SA | PairCorr |
| 0.51 | 9MDA | MEITUAN UNSPADR/2B | PairCorr |
| 0.47 | PP1 | Papa Johns International | PairCorr |
| 0.45 | MLB1 | MercadoLibre | PairCorr |
| 0.33 | 6FO | GOODTECH ASA A | PairCorr |
| 0.6 | AJ91 | DocCheck AG | PairCorr |
| 0.44 | AMI | amalphi ag | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Shanghai Stock performing well and Shanghai Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Shanghai Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CAC1 | 1.03 | 0.10 | 0.06 | (1.27) | 1.09 | 2.03 | 11.63 | |||
| 1MA | 1.99 | 0.45 | 0.19 | 0.67 | 1.78 | 4.67 | 17.86 | |||
| UR3 | 1.69 | (0.04) | 0.00 | (0.03) | 0.00 | 3.29 | 18.61 | |||
| FXL | 0.95 | 0.04 | 0.02 | 42.09 | 1.00 | 2.24 | 5.87 | |||
| UP2 | 2.41 | 0.87 | 0.46 | 1.42 | 1.23 | 6.51 | 30.85 | |||
| AFW | 1.43 | 0.03 | 0.00 | (0.17) | 1.67 | 3.37 | 9.80 | |||
| ALG | 0.22 | 0.01 | 0.00 | (0.03) | 0.00 | 0.72 | 5.76 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Shanghai Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run AI Portfolio Architect Now
AI Portfolio ArchitectUse AI to generate optimal portfolios and find profitable investment opportunities |
| All Next | Launch Module |
Shanghai Pharmaceuticals Corporate Management
Elected by the shareholders, the Shanghai Pharmaceuticals' board of directors comprises two types of representatives: Shanghai Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Shanghai. The board's role is to monitor Shanghai Pharmaceuticals' management team and ensure that shareholders' interests are well served. Shanghai Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Shanghai Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.